
OCCIDENT
Description
OCCIDENT is a Munich-based entrepreneurial venture capital investor, operating as a family-owned investment company. With a strong focus on deep tech, OCCIDENT positions itself as a long-term partner for innovative startups, providing not just capital but also strategic guidance and access to its extensive network. Their investment philosophy is rooted in a commitment to fostering groundbreaking technologies and supporting visionary founders from the early stages of their development.
The firm primarily targets early-stage companies, spanning from seed to Series B rounds, with a clear emphasis on high-potential deep tech sectors. Their core investment areas include Life Sciences, Medical Technology, Diagnostics, Industrial Tech, and Digital solutions. OCCIDENT seeks out companies that are developing disruptive technologies with significant market potential and a clear path to commercialization, often leveraging complex scientific or engineering breakthroughs.
OCCIDENT's investment strategy involves initial cheque sizes that typically range from EUR 0.5 million to EUR 5 million per round, demonstrating their commitment to providing substantial early-stage capital. Beyond the initial investment, they are known for their willingness to participate in follow-on rounds, supporting their portfolio companies through various growth phases. As of recent reports, OCCIDENT has built a robust portfolio comprising more than 30 innovative companies, underscoring their active role in the European deep tech ecosystem. This extensive portfolio reflects their consistent engagement and belief in the long-term value creation of their chosen sectors.
Investor Profile
OCCIDENT has backed more than 38 startups, with 1 new investments in the last 12 months alone. The firm has led 12 rounds, about 32% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Seed rounds (top funding stages).
- Majority of deals are located in Switzerland, Germany, Finland.
- Strong thematic focus on Health Care, Biotechnology, Medical Device.
- Typical check size: $540K – $5.4M.
Stage Focus
- Series A (32%)
- Series B (18%)
- Seed (16%)
- Series C (13%)
- Series Unknown (11%)
- Series D (8%)
- Convertible Note (3%)
Country Focus
- Switzerland (58%)
- Germany (37%)
- Finland (3%)
- Slovenia (3%)
Industry Focus
- Health Care
- Biotechnology
- Medical Device
- Life Science
- Therapeutics
- Health Diagnostics
- Medical
- Pharmaceutical
- Software
- Network Security
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.